Chemoembolization and Bland Embolization of Neuroendocrine Tumor Metastases to the Liver

Kaltsas, 2004, The diagnosis and medical management of advanced neuroendocrine tumors, Endocr Rev, 25, 458, 10.1210/er.2003-0014

Kulke, 1999, Carcinoid tumors, N Engl J Med, 340, 858, 10.1056/NEJM199903183401107

Modlin, 1997, An analysis of 8305 cases of carcinoid tumors, Cancer, 79, 813, 10.1002/(SICI)1097-0142(19970215)79:4<813::AID-CNCR19>3.0.CO;2-2

Chen, 1998, Isolated liver metastases from neuroendocrine tumors: does resection prolong survival?, J Am Coll Surg, 187, 88, 10.1016/S1072-7515(98)00099-4

Sutcliffe, 2004, Management of neuroendocrine liver metastases, Am J Surg, 187, 39, 10.1016/j.amjsurg.2003.04.007

Moertel, 1994, The management of patients with advanced carcinoid tumors and islet cell carcinomas, Ann Int Med, 120, 302, 10.7326/0003-4819-120-4-199402150-00008

Gates, 1999, Chemoembolization of hepatic neoplasms: safety, complications, and when to worry, Radiographics, 19, 399, 10.1148/radiographics.19.2.g99mr08399

Hajarizadeh, 1992, Effective palliative treatment of metastatic carcinoid tumors with intra-arterial chemotherapy/chemoembolization combined with octreotide acetate, Am J Surg, 163, 479, 10.1016/0002-9610(92)90392-5

Mavligit, 1993, Durable hepatic tumor regression after arterial chemoembolization-infusion in patients with islet cell carcinoma of the pancreas metastatic to the liver, Cancer, 72, 375, 10.1002/1097-0142(19930715)72:2<375::AID-CNCR2820720211>3.0.CO;2-D

Therasse, 1993, Transcatheter chemoembolization of progressive carcinoid liver metastasis, Radiology, 189, 541, 10.1148/radiology.189.2.7692465

Perry, 1994, Hepatic arterial chemoembolization for metastatic neuroendocrine tumors, Surgery, 116, 1111

Drougas, 1998, Hepatic artery chemoembolization for management of patients with advanced metastatic carcinoid tumors, Am J Surg, 175, 408, 10.1016/S0002-9610(98)00042-7

Diamandidou, 1998, Two-phase study of hepatic artery vascular occlusion with microencapsulated cisplatin in patients with liver metastases from neuroendocrine tumors, AJR Am J Roentgenol, 170, 339, 10.2214/ajr.170.2.9456942

Loewe, 2003, Permanent transarterial embolization of neuroendocrine metastases of the liver using cyanoacrylate and Lipiodol: assessment of mid- and long-term results, AJR Am J Roentgenol, 180, 1379, 10.2214/ajr.180.5.1801379

Eriksson, 1998, Liver embolizations of patients with malignant neuroendocrine gastrointestinal tumors, Cancer, 83, 2293, 10.1002/(SICI)1097-0142(19981201)83:11<2293::AID-CNCR8>3.0.CO;2-E

Soulen, 1996, CAM/oil/polyvinyl alcohol chemoembolization: life-threatening complications with metastatic carcinoid, J Vasc Interv Radiol, 7, 148

Rajan, 2001, Sarcomas metastatic to the liver: response and survival after cisplatin, doxorubicin, mitomycin-C, Ethiodol, and polyvinyl alcohol chemoembolization, J Vasc Interv Radiol, 12, 187, 10.1016/S1051-0443(07)61824-7

National Cancer Institute. Common Terminology Criteria for Adverse Events v3.0 (CTCAE), August 9, 2006.Available at http://ctep.cancer.gov/forms/CTCAEv3.pdf. Accessed August 28, 2006.

Therasse, 2000, New guidelines to evaluate the response to treatment in solid tumors, J Natl Cancer Inst, 92, 205, 10.1093/jnci/92.3.205

Ruszniewski, 2000, Hepatic arterial chemoembolization in the management of advanced digestive endocrine tumors, Digestion, 62, 79, 10.1159/000051860

Diaco, 1995, Treatment of metastatic carcinoid tumors using multimodality therapy of octreotide acetate, intra-arterial chemotherapy, and hepatic arterial chemoembolization, Am J Surg, 169, 523, 10.1016/S0002-9610(99)80210-4

Clouse, 1994, Hepatic arterial chemoembolization for metastatic neuroendocrine tumors, Digestion, 55, 92, 10.1159/000201208